{
    "2021-12-14": [
        [
            {
                "time": "",
                "original_text": "用茅台和劳力士换玲娜贝儿，到底值不值？",
                "features": {
                    "keywords": [
                        "茅台",
                        "劳力士",
                        "玲娜贝儿"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "CDMO巨头正布局制药专用设备领域",
                "features": {
                    "keywords": [
                        "CDMO",
                        "制药",
                        "设备",
                        "布局"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "制造业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "平安证券：海内外疫情继续，新冠检测试剂销量有望增长",
                "features": {
                    "keywords": [
                        "平安证券",
                        "疫情",
                        "新冠检测试剂",
                        "销量",
                        "增长"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "凯莱英(06821.HK)获FIDELITY CONTRAFUND增持5.75万股",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "FIDELITY CONTRAFUND",
                        "增持",
                        "股份"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}